SpringWorks Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
SpringWorks Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2018 to Q2 2024.
  • SpringWorks Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $26.2M, a 14.2% increase year-over-year.
  • SpringWorks Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $105M, a 25.1% increase year-over-year.
  • SpringWorks Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $94.5M, a 29.6% increase from 2022.
  • SpringWorks Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $73M, a 89.8% increase from 2021.
  • SpringWorks Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $38.4M, a 283% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $105M $26.2M +$3.27M +14.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $102M $30.5M +$7.07M +30.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $94.5M $25.1M +$6.14M +32.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $88.4M $23.1M +$4.58M +24.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $83.8M $23M +$4.55M +24.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $79.3M $23.4M +$6.3M +36.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $73M $18.9M +$7.04M +59.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $65.9M $18.5M +$7.81M +72.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $58.1M $18.4M +$9.63M +110% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $48.5M $17.1M +$10M +142% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $38.4M $11.9M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $10.7M +$7.67M +252% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $8.8M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $7.06M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 $3.04M +$2.26M +286% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q3 2019 $788K +$553K +235% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-12
Q3 2018 $235K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.